Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
Dear Editor,. Inferior outcomes have been observed with SARS-CoV-2 infection in patients with chronic myeloid neoplasms, emphasising the...